Quest Diagnostics Incorporated Revenue 2007–2025
Quest Diagnostics Incorporated reported $11.04B of revenue for fiscal 2025. That was 11.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +16.9%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $11.04B | +11.8% |
| FY 2024 | $9.87B | +6.7% |
| FY 2023 | $9.25B | -6.4% |
| FY 2022 | $9.88B | -8.4% |
| FY 2021 | $10.79B | +14.3% |
| FY 2020 | $9.44B | +22.1% |
| FY 2019 | $7.73B | +2.6% |
| FY 2018 | $7.53B | +1.7% |
| FY 2017 | $7.40B | +2.6% |
| FY 2016 | $7.21B | -3.7% |
| FY 2015 | $7.49B | +0.8% |
| FY 2014 | $7.43B | +4.0% |
| FY 2013 | $7.15B | -3.2% |
| FY 2012 | $7.38B | -0.1% |
| FY 2011 | $7.39B | +1.8% |
| FY 2010 | $7.26B | -2.6% |
| FY 2009 | $7.46B | +2.8% |
| FY 2008 | $7.25B | +8.1% |
| FY 2007 | $6.70B | — |
Source: Quest Diagnostics Incorporated SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open DGX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Quest Diagnostics Incorporated reported $11.04B of revenue for fiscal 2025. That was 11.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +16.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Quest Diagnostics Incorporated
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeQuest Diagnostics Incorporated — frequently asked questions
What is Quest Diagnostics Incorporated's revenue?
Quest Diagnostics Incorporated (DGX) reported revenue of $11.04B for fiscal year 2025, per its SEC filings.
How has Quest Diagnostics Incorporated's revenue changed over time?
Between fiscal 2007 and 2025, DGX's revenue grew at roughly 2.8% per year (compound annual rate), from $6.70B to $11.04B.
Where does this data come from?
Figures are computed from Quest Diagnostics Incorporated's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.